Anti-IL-12 (IL-12a & IL-12b) Antibody (Briakinumab)
Catalog No.
F1392
Anti-IL-12 (IL-12a & IL-12b) Antibody (Briakinumab)
Featured Products
Briakinumab (ABT-874) is a fully human anti-IL-12/23p40 monoclonal antibody. Briakinumab targets and neutralizes IL-12 and IL-23. Briakinumab is being investigated in rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
143.86 kDa
Dry ice
339308-60-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
ABT-874, J695, BSF 415977
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P29459
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
IL-12
Please avoid freeze-thaw cycles.